Clinical Trial Update: A Study to Evaluate the Incidence of Hypersensitivity After Administration of Sugammadex in Healthy Participants (MK-8616-101) [Phase 1]

View source ↗

Summary

Phase 1 trial assessing hypersensitivity incidence after sugammadex administration in healthy participants; results completed with posted results in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaphylaxis
• Hypersensitivity

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypersensitivity, Anaphylaxis | Phase 1 | Status: COMPLETED | Results posted: 2015-10-02